PRESS RELEASE published on 12/15/2025 at 08:00, 9 days 15 hours ago STMicroelectronics and SpaceX celebrate a decade-long partnership key to Starlink global connectivity STMicroelectronics and SpaceX mark a decade-long partnership enabling global Starlink connectivity with custom-made chips and high-performing antennas. Collaboration focuses on next-gen solutions Partnership Connectivity STMicroelectronics SpaceX Starlink
PRESS RELEASE published on 12/15/2025 at 07:30, 9 days 15 hours ago Appointment of François Michel as Chief Executive Officer of the GTT Group GTT Group appoints François Michel as Chief Executive Officer, effective January 5, 2026, emphasizing strategic vision and technological expertise Technology Strategic Vision Chief Executive Officer GTT Group François Michel
PRESS RELEASE published on 12/15/2025 at 07:30, 9 days 15 hours ago Nomination de François Michel en qualité de Directeur général du groupe GTT Nomination de François Michel en qualité de Directeur général du groupe GTT. François Michel, expert en technologie et stratégie, prendra ses fonctions le 5 janvier 2026 pour renforcer l'innovation et la diversification de GTT Innovation Nomination Directeur Général GTT François Michel
PRESS RELEASE published on 12/15/2025 at 07:05, 9 days 16 hours ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
PRESS RELEASE published on 12/15/2025 at 07:05, 9 days 16 hours ago Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
PRESS RELEASE published on 12/15/2025 at 07:05, 9 days 16 hours ago Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive Sanofi annonce l'arrêt du développement du tolebrutinib dans la sclérose en plaques primaire progressive après l'étude de phase 3 PERSEUS. Profil de sécurité cohérent, analyse détaillée à venir Sclérose En Plaques Sanofi Étude Tolebrutinib PERSEUS
PRESS RELEASE published on 12/15/2025 at 07:00, 9 days 16 hours ago Swiss Life: change on the Board of Directors in the coming year Swiss Life announces changes on the Board of Directors for the upcoming year, with Henry Peter and Adrienne Corboud Fumagalli stepping down, and Luisa Delgado and Patrick Frost joining Board Of Directors Swiss Life Patrick Frost Henry Peter Adrienne Corboud Fumagalli
PRESS RELEASE published on 12/15/2025 at 07:00, 9 days 16 hours ago Swiss Life: changement au conseil d’administration l’année prochaine Changement au conseil d'administration de Swiss Life: Henry Peter et Adrienne Corboud Fumagalli ne seront pas réélus en 2026, Luisa Delgado et Patrick Frost les remplaceront Conseil D'administration Nominations Election Swiss Life Entreprise
PRESS RELEASE published on 12/15/2025 at 07:00, 9 days 16 hours ago HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma HBM Healthcare Investments sells majority stake in Swixx Biopharma to SK Capital Partners, creating value and boosting NAV per share by 5% Healthcare Sector HBM Healthcare Investments Investment Agreement Swixx BioPharma SK Capital Partners
PRESS RELEASE published on 12/15/2025 at 07:00, 9 days 16 hours ago Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions Business Combination Relief Therapeutics NeuroX MindMaze Therapeutics Neurological Care
Published on 12/24/2025 at 21:10, 2 hours 17 minutes ago Golden Harp Resources Inc. Mails Management Information Circular for January 6, 2026 Annual and Special Meeting and Provides Additional Information Regarding Proposed Related Party Transaction
Published on 12/24/2025 at 15:25, 8 hours 2 minutes ago CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Published on 12/24/2025 at 14:00, 9 hours 27 minutes ago Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
Published on 12/24/2025 at 14:00, 9 hours 27 minutes ago Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
Published on 12/24/2025 at 16:30, 6 hours 57 minutes ago ABB Ltd: ABB share buybacks - December 18, 2025 - December 23, 2025
Published on 12/24/2025 at 15:07, 8 hours 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/24/2025 at 15:06, 8 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 12/24/2025 at 15:06, 8 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/24/2025 at 15:05, 8 hours 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 12/23/2025 at 12:48, 1 day 10 hours ago Evolution des droits de vote au 23 décembre 2025
Published on 12/22/2025 at 18:33, 2 days 4 hours ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 2 days 5 hours ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025